Galapagos NV
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of …
Biotechnology
BE, Mechelen [HQ]
Cash Flow Statements
15 Sheets · Starting from 2023In Million EUR. Margins, Growth Rates In %
| Metric | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||
| Operating Cash Flow (OCF) | 6.00 | -18.00 | -11.00 | 64.00 | - - | -75.00 | -114.00 | 239.00 | -147.00 | -142.00 | 3,208.00 | -427.00 | -503.00 | -500.00 | -405.00 | |
| Operating Cash (Net) | 6.00 | -18.00 | -11.00 | 64.00 | - - | -75.00 | -114.00 | 239.00 | -147.00 | -142.00 | 3,208.00 | -427.00 | -503.00 | -500.00 | -405.00 | |
| Accounts Receivable | - - | - - | - - | - - | 1.00 | - - | - - | - - | - - | - - | -67.00 | -177.00 | 79.00 | 68.00 | -39.00 | |
| Accounts Payable | - - | - - | - - | - - | 2.00 | - - | - - | - - | - - | - - | 79.00 | 31.00 | -35.00 | -2.00 | 31.00 | |
|
Working Capital
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Change | -4.00 | -28.00 | 8.00 | 57.00 | 3.00 | -50.00 | -34.00 | 235.00 | -78.00 | -133.00 | 2,816.00 | -353.00 | -430.00 | -351.00 | -692.00 | |
| Other WC | -6.00 | -29.00 | 7.00 | 57.00 | - - | -49.00 | -34.00 | 235.00 | -78.00 | -133.00 | 2,804.00 | -207.00 | -453.00 | -383.00 | -661.00 | |
| Investing Activities | ||||||||||||||||
| Used Cash (Net) | -4.00 | -20.00 | 2.00 | -6.00 | -8.00 | 120.00 | -4.00 | -7.00 | - - | -15.00 | -3,764.00 | 757.00 | 541.00 | -1,245.00 | 71.00 | |
| Capital Expenditure | -5.00 | -4.00 | -5.00 | -6.00 | -7.00 | -2.00 | -6.00 | -4.00 | -7.00 | -13.00 | -45.00 | -91.00 | -57.00 | -36.00 | -19.00 | |
| Purchases of Investments | - - | - - | - - | - - | - - | - - | - - | -2.00 | - - | -4.00 | -4,787.00 | -4,576.00 | -1,561.00 | -2,728.00 | -3,404.00 | |
| Sale/Maturity of Investment | - - | - - | - - | - - | - - | - - | - - | - - | - - | 2.00 | 1,063.00 | 5,421.00 | 2,131.00 | 1,641.00 | 3,484.00 | |
| Property, Plant, Equipment (P&PE) | -5.00 | -4.00 | -5.00 | -6.00 | -7.00 | -2.00 | -6.00 | -4.00 | -7.00 | -13.00 | -45.00 | -91.00 | -57.00 | -36.00 | -19.00 | |
| Acquisitions (Net) | - - | -15.00 | 8.00 | - - | -1.00 | 130.00 | - - | - - | - - | 3.00 | -18.00 | -45.00 | 28.00 | -115.00 | -7.00 | |
| Other Investing Activities | - - | - - | -1.00 | - - | - - | -8.00 | 1.00 | - - | 4.00 | -3.00 | 23.00 | 48.00 | - - | -6.00 | 17.00 | |
| Financing Activities | ||||||||||||||||
| Used Cash (Net) | -18.00 | -31.00 | - - | -4.00 | -55.00 | -4.00 | -271.00 | -395.00 | -353.00 | -287.00 | -1,335.00 | -22.00 | -3.00 | -1.00 | -5.00 | |
| Debt Repayment | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | -5.00 | -6.00 | -7.00 | -8.00 | -6.00 | |
| Dividends Paid | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Common Stock
|
- - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Issued | - - | - - | - - | 2.00 | 54.00 | 4.00 | 271.00 | - - | 363.00 | 296.00 | 960.00 | 28.00 | 3.00 | 6.00 | 1.00 | |
| Repurchased | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Other Financing Activities | 19.00 | 31.00 | - - | 1.00 | 1.00 | - - | - - | 396.00 | -10.00 | -8.00 | 380.00 | 28.00 | 3.00 | 6.00 | 1.00 | |
| Cash Balances | ||||||||||||||||
| Begin of Period | 27.00 | 47.00 | 40.00 | 32.00 | 94.00 | 138.00 | 187.00 | 340.00 | 973.00 | 1,151.00 | 1,290.00 | 1,861.00 | 2,143.00 | 2,233.00 | 508.00 | |
| End of Period | 47.00 | 40.00 | 32.00 | 94.00 | 141.00 | 187.00 | 340.00 | 973.00 | 1,151.00 | 1,290.00 | 1,861.00 | 2,143.00 | 2,233.00 | 508.00 | 166.00 | |
| Change | 20.00 | -6.00 | -7.00 | 62.00 | 46.00 | 49.00 | 152.00 | 632.00 | 177.00 | 139.00 | 570.00 | 281.00 | 90.00 | -1,725.00 | -341.00 | |
| Non-Cash Balances | ||||||||||||||||
| Depreciation and Amortization | 6.00 | 11.00 | 12.00 | 9.00 | 8.00 | 4.00 | 3.00 | 4.00 | 4.00 | 5.00 | 12.00 | 18.00 | 34.00 | 65.00 | 43.00 | |
| Stock Based Compensation | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 5.00 | 11.00 | 16.00 | - - | 38.00 | 79.00 | 70.00 | 88.00 | 56.00 | |
| Other | - - | -4.00 | -1.00 | 1.00 | -2.00 | -68.00 | 30.00 | -65.00 | 26.00 | -11.00 | 190.00 | 131.00 | -7.00 | -88.00 | -37.00 | |
| Highlighted metrics | ||||||||||||||||
| Free Cash Flow (FCF) | 1.00 | -22.00 | -17.00 | 57.00 | -7.00 | -78.00 | -121.00 | 234.00 | -154.00 | -156.00 | 3,162.00 | -518.00 | -561.00 | -537.00 | -425.00 | |
| Cash Conversion Cycle (CCC) | 68.00 | 124.00 | 62.00 | -76.00 | -172.00 | -25.00 | 38.00 | -14.00 | 41.00 | -34.00 | -86.00 | 13.00 | -25,387.00 | -2,372.00 | -515.00 | |
| Invested Capital | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
|
Other Operating Inflows/Outflows
|
||||||||||||||||
| Forex Effect on Cash | - - | - - | - - | - - | - - | - - | - - | 4.00 | -27.00 | 10.00 | -9.00 | -70.00 | 56.00 | 22.00 | -1.00 |